The condition lacks a definitive diagnostic test and is commonly diagnosed by ruling out other disorders.
During the study, the researchers observed that vibrational characteristics of graphene changed in a unique manner when in contact with cerebrospinal fluid from ALS patients, compared to those with multiple sclerosis or no neurodegenerative disease.
Findings showed that the unique changes accurately predicted if the cerebrospinal fluid was taken from ALS or MS or non-neurodegenerative disorder patient.
